| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Serina Therapeutics, Inc. | SVP, CMC & Formulation | Stock Option (right to buy) | 69,000 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | 03 Feb 2026 | 1 | $0 | 4 | SVP, CMC & Formulation | 17 Feb 2026, 08:29 |
| SER | Serina Therapeutics, Inc. | 15 Jul 2024 | 1 | $0 | 4 | SVP, CMC & Formulation | 17 Jul 2024, 17:10 |
| SER | Serina Therapeutics, Inc. | 15 Jul 2024 | 0 | $0 | 3 | SVP, CMC & Formulation | 17 Jul 2024, 17:07 |